Health system costs of a breast cancer early diagnosis programme in a rural district of Rwanda: a retrospective, cross-sectional economic analysis.
Health system costs of a breast cancer early diagnosis programme in a rural district of Rwanda: a retrospective, cross-sectional economic analysis.
复制标题
卢旺达一个农村地区乳腺癌早期诊断项目的卫生系统成本:一项回顾性横断面经济分析
DOI:
10.1136/bmjopen-2022-062357
复制
发表时间:
2022-06-30
期刊:
影响因子:
2.9
通讯作者:
Pace, Lydia E.
中科院分区:
文献类型:
--
作者:
Nambaziira, Rashidah;Niteka, Lysa Carolle;Dusengimana, Jean Marie Vianney;Ruhumuriza, John;Bhangdia, Kayleigh Pavitra;Mugunga, Jean Claude;Uwineza, Marie Louise;Rugema, Vestine;Erfani, Parsa;Shyirambere, Cyprien;Shulman, Lawrence N.;Rabideau, Melany;Pace, Lydia E.
This study aimed to quantify the health system cost of the first 2 years of a Breast Cancer Early Detection (BCED) programme in a rural district in Rwanda. We also aimed to estimate the cost of implementing the programme in other districts with different referral pathways and identify opportunities for enhanced cost efficiency. Retrospective, cross-sectional analysis using time-driven activity-based costing, based on timed patient clinical encounters, retrospective patient data and unit costs of resources abstracted from administrative and finance records. The BCED programme focused on timely evaluation of individuals with breast symptoms. The study evaluated the health system cost of the BCED programme at seven health centres (HCs) in Burera district and Butaro Cancer Centre of Excellence (BCCOE) at Butaro District Hospital. Health system costs per patient visit and cost per cancer diagnosed were quantified. Total start-up and recurring operational costs were also estimated, as well as health system costs of different scale-up adaptations in other districts. One-time start-up costswere US$36 917, recurring operational costswere US$67 711 and clinical costswere US$14 824 over 2 years. Clinical breast examinations (CBE) at HCs cost US$3.27/visit. At BCCOE, CBE-only visits cost US$13.47/visit, CBE/ultrasound US$14.79/visit and CBE/ultrasound/biopsy/pathology US$147.81/visit. Overall, clinical cost per breast cancer diagnosed was US$1482. Clinicalcost drivers were personnel at HCs (55%) and biopsy/pathology supplies at BCCOE (46%). In other districts, patients experience a longer breast evaluation pathway, adding about US$14.00/patient; this could be decreased if ultrasound services were decentralised. Clinical costs associated with BCED services at HCs were modest, similar to other general outpatient services. The BCED programme’s start-up and operational costs were high but could be reduced by using local trainers and virtual mentorship. In other districts, decentralising ultrasound and/or biopsies to district hospitals could reduce costs.
登录
查看更多内容
影响因子:
2.8
作者:
Lopes, Lygia Vieira;Miguel, Fernando;Santos, Lucio Lara
通讯作者:
Santos, Lucio Lara
影响因子:
2.3
作者:
Odhiambo, Jackline;Ruhumuriza, John;Hedt-Gauthier, Bethany L.
通讯作者:
Hedt-Gauthier, Bethany L.
影响因子:
6.2
作者:
Yip, Cheng-Har;Smith, Robert A.;Shastri, Surendra
通讯作者:
Shastri, Surendra
影响因子:
3.1
作者:
Ruhumuriza J;Odhiambo J;Riviello R;Lin Y;Nkurunziza T;Shrime M;Maine R;Omondi JM;Mpirimbanyi C;de la Paix Sebakarane J;Hagugimana P;Rusangwa C;Hedt-Gauthier B
通讯作者:
Hedt-Gauthier B
影响因子:
--
作者:
Pace, Lydia E.;Dusengimana, Jean Marie Vianney;Mpunga, Tharcisse
通讯作者:
Mpunga, Tharcisse